These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26523992)

  • 1. Soluble endothelial cell selective adhesion molecule and cardiovascular outcomes in patients with stable coronary disease: A report from the Heart and Soul Study.
    Park M; Kulkarni A; Beatty A; Ganz P; Regan M; Vittinghoff E; Whooley M
    Atherosclerosis; 2015 Dec; 243(2):546-52. PubMed ID: 26523992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study.
    Park M; Vittinghoff E; Ganz P; Peralta CA; Whooley M; Shlipak MG
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):231-6. PubMed ID: 24177327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study.
    Beatty AL; Zhang MH; Ku IA; Na B; Schiller NB; Whooley MA
    Atherosclerosis; 2012 Feb; 220(2):587-92. PubMed ID: 22196150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population.
    Ren HY; Khera A; de Lemos JA; Ayers CR; Rohatgi A
    Am Heart J; 2017 Sep; 191():55-61. PubMed ID: 28888270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul Study.
    Park M; Maristany D; Huang D; Shlipak MG; Whooley M
    Atherosclerosis; 2017 Aug; 263():68-73. PubMed ID: 28601698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.
    Hsu CY; Tseng WK; Wu YW; Lin TH; Yeh HI; Chang KC; Wang JH; Chou RH; Huang CY; Huang PH; Leu HB; Yin WH; Wu CC; Lin SJ; Chen JW
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1240-1252. PubMed ID: 30943772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule.
    Rohatgi A; Owens AW; Khera A; Ayers CR; Banks K; Das SR; Berry JD; McGuire DK; de Lemos JA
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1684-90. PubMed ID: 19759376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study.
    Ku IA; Farzaneh-Far R; Vittinghoff E; Zhang MH; Na B; Whooley MA
    Atherosclerosis; 2011 Aug; 217(2):503-8. PubMed ID: 21176905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
    Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study.
    Mishra RK; Judson G; Christenson RH; DeFilippi C; Wu AHB; Whooley MA
    Cardiology; 2017; 137(4):201-206. PubMed ID: 28445886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
    Dupont M; Wu Y; Hazen SL; Tang WH
    Circ Heart Fail; 2012 Sep; 5(5):602-9. PubMed ID: 22899766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Lim SS; Yang YL; Chen SC; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Chou CY; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Hsu PF; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB
    Atherosclerosis; 2020 Mar; 297():40-46. PubMed ID: 32062138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Plasma 7-Ketocholesterol With Cardiovascular Outcomes and Total Mortality in Patients With Coronary Artery Disease.
    Song J; Wang D; Chen H; Huang X; Zhong Y; Jiang N; Chen C; Xia M
    Circ Res; 2017 May; 120(10):1622-1631. PubMed ID: 28381400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
    J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
    Agarwala A; Pokharel Y; Saeed A; Sun W; Virani SS; Nambi V; Ndumele C; Shahar E; Heiss G; Boerwinkle E; Konety S; Hoogeveen RC; Ballantyne CM
    Atherosclerosis; 2017 Jul; 262():131-137. PubMed ID: 28554015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study.
    Garimella PS; Katz R; Patel KV; Kritchevsky SB; Parikh CR; Ix JH; Fried LF; Newman AB; Shlipak MG; Harris TB; Sarnak MJ;
    Circ Heart Fail; 2016 Jan; 9(1):e002124. PubMed ID: 26721912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.
    Beatty AL; Ku IA; Christenson RH; DeFilippi CR; Schiller NB; Whooley MA
    JAMA Intern Med; 2013 May; 173(9):763-9. PubMed ID: 23568589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
    Ix JH; Shlipak MG; Chertow GM; Whooley MA
    Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.